Islam Saqib
SEC insider (Form 3/4/5 filer). CIK 0001575408. Director at ARS Pharmaceuticals, Inc. (SPRY) and 2 other issuers. 25 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in SAN DIEGO, CA.
Companies Islam Saqib has filed insider reports for
- ARS Pharmaceuticals, Inc. (SPRY): Director
- SpringWorks Therapeutics, Inc. (SWTX): Director, Officer, Chief Executive Officer
- Passage BIO, Inc. (PASG): Director
Islam Saqib
CIK: 0001575408
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Jun 24, 2026SPRY
ARS Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
30K shares- - Jul 1, 2025SWTX
SpringWorks Therapeutics, Inc.
DispositionDirect954.9K shares- - Jun 25, 2025SPRY
ARS Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
30K shares- - May 28, 2025PASG
Passage BIO, Inc.
AwardDirectDirector Stock Option (right to buy)
201.9K shares- - Mar 3, 2025SWTX
SpringWorks Therapeutics, Inc.
SaleDirect11.6K shares at avg. $55.15$640K - Mar 3, 2025SWTX
SpringWorks Therapeutics, Inc.
SaleDirect1.4K shares at avg. $56.13$79K - Mar 3, 2025SWTX
SpringWorks Therapeutics, Inc.
SaleDirect23.6K shares at avg. $54.24$1.3M - Mar 3, 2025SWTX
SpringWorks Therapeutics, Inc.
SaleDirect600 shares at avg. $56.89$34K - Mar 3, 2025SWTX
SpringWorks Therapeutics, Inc.
SaleDirect11.8K shares at avg. $52.97$625K - Feb 27, 2025SWTX
SpringWorks Therapeutics, Inc.
Tax PaymentDirect30.8K shares at avg. $53.41$1.6M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 24, 2026 |  SPRY ARS Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Jul 1, 2025 |  SWTX SpringWorks Therapeutics, Inc. | Disposition | 954,869 | - | - | Direct |
| Jun 25, 2025 | SPRY ARS Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| May 28, 2025 |  PASG Passage BIO, Inc. | Award Director Stock Option (right to buy) | 201,857 | - | - | Direct |
| Mar 3, 2025 | SWTX SpringWorks Therapeutics, Inc. | Sale | 11,600 | $55.15 | $639,783 | Direct |
| Mar 3, 2025 | SWTX SpringWorks Therapeutics, Inc. | Sale | 1,400 | $56.13 | $78,588 | Direct |
| Mar 3, 2025 | SWTX SpringWorks Therapeutics, Inc. | Sale | 23,600 | $54.24 | $1,280,135 | Direct |
| Mar 3, 2025 | SWTX SpringWorks Therapeutics, Inc. | Sale | 600 | $56.89 | $34,134 | Direct |
| Mar 3, 2025 | SWTX SpringWorks Therapeutics, Inc. | Sale | 11,800 | $52.97 | $625,017 | Direct |
| Feb 27, 2025 | SWTX SpringWorks Therapeutics, Inc. | Tax Payment | 30,756 | $53.41 | $1,642,678 | Direct |
1-10 of 25 transactions